Altamira Therapeutics (CYTO) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free CYTO Stock Alerts $1.69 +0.09 (+5.63%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAltamira reports publication of positive results from NASAR clinical trial with Bentriomsn.com - April 24 at 4:19 PMAltamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journalglobenewswire.com - April 24 at 8:47 AMDiamond Equity Research Initiates Coverage on Altamira Therapeutics Ltd. (NASDAQ: CYTO)finance.yahoo.com - April 15 at 10:31 AMAltamira Therapeutics Ltd. (CYTO) Q4 2023 Earnings Call Transcriptseekingalpha.com - April 12 at 12:27 PMAltamira Therapeutics Ltd. (NASDAQ:CYTO) Q4 2023 Earnings Call Transcriptmsn.com - April 12 at 12:27 PMAltamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Resultsfinance.yahoo.com - April 10 at 12:42 PMAltamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024globenewswire.com - April 4 at 8:45 AMAltamira Therapeutics Ltd: Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccinesfinanznachrichten.de - March 26 at 12:40 AMCrude Oil Moves Higher; US New Home Sales Fall In Februarymarkets.businessinsider.com - March 26 at 12:40 AMWhy Altamira Therapeutics Stock Is Racing Highermsn.com - March 25 at 7:39 PMAltamira stock rallies 44% on Univercells mRNA collaborationmsn.com - March 25 at 7:39 PMAltamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccinesglobenewswire.com - March 25 at 8:47 AMAltamira Therapeutics’ Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed Journalfinance.yahoo.com - February 7 at 4:15 PMAltamira Therapeutics Shares Rise 13% After Filing Second Provisional Patent Applicationmarketwatch.com - January 24 at 1:38 PMAltamira Therapeutics stock jumps 7% as it files for second patentmsn.com - January 24 at 1:38 PMAltamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatmentfinance.yahoo.com - January 24 at 1:38 PMAltamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summitfinance.yahoo.com - January 8 at 8:50 AMAltamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirementfinance.yahoo.com - December 29 at 9:31 AMmarketbeat.com - December 13 at 9:45 AMmarketbeat.com - December 13 at 6:04 AMAltamira shares sink over 40% on corporate, stock split updatesmsn.com - December 11 at 1:07 PMWhy Altamira Therapeutics (CYTO) Stock Is Down 50% Todaymsn.com - December 11 at 1:07 PMAltamira Therapeutics Provides Investor and Business Updatefinance.yahoo.com - December 11 at 1:07 PMAltamira Therapeutics to Host Investor & Business Update Call on December 11thfinance.yahoo.com - December 5 at 3:43 PMAltamira Therapeutics to Host Investor & Business Update Call on December 11thfinance.yahoo.com - December 5 at 3:43 PMThinking about buying stock in Macy's Inc, Altamira Therapeutics, Neurosense Therapeutics, Cytosorbents, or Designer Brands?benzinga.com - December 5 at 10:42 AMAltamira Therapeutics Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirementfinance.yahoo.com - November 29 at 10:43 AMTrending tickers: Microsoft | Bitcoin | Altamira | Ashteaduk.finance.yahoo.com - November 20 at 7:52 AMAltamira stock surges after deal to sell 51% stake in Medicamsn.com - November 17 at 2:54 PMWhy Is Altamira Therapeutics (CYTO) Stock Up 160% Today?msn.com - November 17 at 2:54 PMAltamira Therapeutics Shares Surge on Sale of Bentrio Unitmarketwatch.com - November 17 at 9:53 AMAltamira Therapeutics Announces Partial Spin-Off of Bentrio® Businessfinance.yahoo.com - November 17 at 9:53 AMAltamira Therapeutics Announces European Patent Office Decision to Grant for Patent Application Covering Intranasal Betahistinefinance.yahoo.com - November 10 at 10:07 AMWhy Is Altamira Therapeutics (CYTO) Stock Up 28% Today?msn.com - November 3 at 10:43 AMAltamira Therapeutics Shares Rise on Positive Bentrio Trial Resultsmarketwatch.com - September 14 at 2:53 PMAltamira Therapeutics Reports Additional Significant Efficacy Outcomes from Bentrio Clinical Trial in Seasonal Allergic Rhinitisfinance.yahoo.com - September 14 at 9:53 AMAltamira Therapeutics Ltd. (NASDAQ:CYTO) Q2 2023 Earnings Call Transcriptinsidermonkey.com - September 13 at 10:01 AMAltamira Therapeutics Ltd: Altamira Therapeutics Provides Business Update and First Half 2023 Financial Resultsfinanznachrichten.de - September 12 at 9:54 AMAltamira Therapeutics Provides Business Update and First Half 2023 Financial Resultsfinance.yahoo.com - September 12 at 9:54 AMAltamira Therapeutics Ltd Registered Shs hosts conference call for investorsmarkets.businessinsider.com - September 8 at 9:04 PMAltamira Therapeutics to Host First Half 2023 Financial Results and Business Update Call on September 12thfinance.yahoo.com - September 6 at 9:42 AMAltamira Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13uk.finance.yahoo.com - August 23 at 5:47 PMAltamira Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13finance.yahoo.com - August 23 at 5:47 PMAltamira Therapeutics and Pharma Nordic Collaborate for Marketing and Distribution of Bentrio in Scandinaviafinance.yahoo.com - July 20 at 9:52 AMAltamira Therapeutics Announces Publication of Positive Results from Clinical Trial with Bentrio in House Dust Mite Allergy in Leading Peer Reviewed Journalfinance.yahoo.com - July 17 at 2:31 PMWhy Altamira Therapeutics (CYTO) Stock Is Getting Hammeredmsn.com - July 6 at 10:56 AMAltamira Therapeutics Announces Pricing of $5.0 Million Public Offeringfinance.yahoo.com - July 6 at 10:56 AMAltamira Therapeutics Announces Collaboration with Heqet Therapeutics on Nanoparticle-Delivered Non-Coding RNAs for Cardiac Regenerationfinance.yahoo.com - July 5 at 11:46 AMAltamira Therapeutics Announces IND Clearance by U.S. FDA for AM-125 in Acute Vestibular Syndromefinance.yahoo.com - June 15 at 12:34 PMAltamira Therapeutics Announces Publication of Peer-Reviewed Article on Peptide-Based RNA Delivery for Extrahepatic Targetsfinance.yahoo.com - May 31 at 7:34 PM Get Altamira Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTO and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. CYTO Media Mentions By Week CYTO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYTO News Sentiment▼0.700.32▲Average Medical News Sentiment CYTO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYTO Articles This Week▼31▲CYTO Articles Average Week Get Altamira Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CWBR News CYCC News ONCO News RNAZ News AGRX News DRMA News CNSP News NTBL News SLRX News SXTP News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CYTO) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Altamira Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
